Physician
Dahan, Mazen
Dahan, Mazen was paid $2.61M by Medicaid between Jan 2018 and Dec 2024, across 75 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 57% of everything it billed.
33Billing provider infoDAHAN, MAZEN
PUYALLUP, WA 98372
PUYALLUP, WA 98372
33aNPI1578671830assigned 08/28/2006
33bProvider typePediatrics Physician
28Total paid$2.61M
24GClaims100,159
24DCodes billed75
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Washington
Rank by total paid#12 of 110
Median peer was paid$57K
This provider vs. median46×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,598 | $168K | |
| 2019 | 7,848 | $150K | |
| 2020 | 7,287 | $87K | |
| 2021 | 12,786 | $226K | |
| 2022 | 21,365 | $753K | |
| 2023 | 20,991 | $644K | |
| 2024incomplete | 22,284 | $578K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 57% | 25,998 | 18,714 | $1.47M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 6,669 | 5,621 | $291K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.5% | 2,492 | 2,167 | $145K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.5% | 1,846 | 1,740 | $91K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.1% | 1,773 | 1,622 | $81K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.7% | 1,116 | 1,067 | $71K |
| 87631 | 2.3% | 781 | 713 | $59K | |
| D1208 | Topical application of fluoride, excluding varnish | 1.2% | 2,610 | 2,518 | $31K |
| 92587 | 1.1% | 4,198 | 3,798 | $30K | |
| 99383 | <1% | 361 | 349 | $25K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 774 | 653 | $25K |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,280 | 7,662 | $21K |
63 more codes
| 99497 | <1% | 881 | $20K | |
| 92551 | <1% | 4,156 | $16K | |
| 99381 | <1% | 168 | $14K | |
| 69210 | <1% | 938 | $13K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 336 | $13K |
| 90686 | <1% | 1,577 | $13K | |
| 99382 | <1% | 149 | $13K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 861 | $12K |
| 90670 | <1% | 1,297 | $12K | |
| 99174 | <1% | 6,356 | $9K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 520 | $9K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 470 | $9K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 428 | $9K |
| 92567 | <1% | 1,636 | $8K | |
| 81002 | <1% | 4,660 | $8K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 54 | $7K |
| 90651 | <1% | 742 | $7K | |
| 85018 | <1% | 5,586 | $7K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,126 | $7K |
| 90633 | <1% | 648 | $6K | |
| 90680 | <1% | 594 | $5K | |
| 90710 | <1% | 527 | $5K | |
| 90697 | <1% | 415 | $4K | |
| 90700 | <1% | 436 | $4K | |
| 90648 | <1% | 555 | $4K | |
| 90734 | <1% | 358 | $3K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 58 | $3K |
| 90685 | <1% | 301 | $3K | |
| 99460 | <1% | 31 | $3K | |
| 99384 | <1% | 26 | $2K | |
| 83655 | <1% | 316 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 226 | $2K |
| 36416 | <1% | 370 | $1K | |
| 99188 | <1% | 692 | $1K | |
| 90715 | <1% | 157 | $1K | |
| 90713 | <1% | 123 | $1K | |
| 94060 | <1% | 77 | $1K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 63 | $1K |
| 90620 | <1% | 116 | $1K | |
| 17110 | <1% | 39 | $1K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 19 | $692.70 |
| 94016 | <1% | 77 | $682.94 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 55 | $597.74 |
| 99173 | <1% | 465 | $536.22 | |
| 90656 | <1% | 142 | $479.03 | |
| 90696 | <1% | 32 | $405.05 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 16 | $354.39 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 16 | $354.39 |
| 99072 | <1% | 2,080 | $345.00 | |
| 87430 | <1% | 45 | $317.52 | |
| 90473 | <1% | 25 | $238.56 | |
| 90744 | <1% | 15 | $224.09 | |
| 94664 | <1% | 132 | $209.66 | |
| 90716 | <1% | 45 | $205.56 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 142 | $152.69 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 58 | $147.44 |
| 90707 | <1% | 29 | $58.74 | |
| 96127 | <1% | 18 | $30.56 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 16 | $3.06 |
| G0009 | Administration of pneumococcal vaccine | <1% | 44 | $0.15 |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 0% | 35 | $0.00 |
| 96160 | 0% | 15 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 671 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.